March 25, 2022 March 25, 2022Categories News StoriesEnrollment in TMIST breast cancer screening trial surpasses halfway mark; Black participation rises above 20%
March 25, 2022 March 25, 2022Categories Press ReleasesPress Release: Enrollment in TMIST breast cancer screening trial surpasses halfway mark; recruitment of women from diverse backgrounds is key to success
March 17, 2022 March 17, 2022Categories News StoriesNCI-MATCH umbrella trial adds arm for LAG-3 expressing, mismatch repair deficient cancers
March 16, 2022 March 16, 2022Categories Press ReleasesPress Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations
March 15, 2022 March 15, 2022Categories News StoriesThe results of the EA8141 phase II trial are part of mounting evidence showing the benefits of neoadjuvant chemotherapy
March 10, 2022 March 10, 2022Categories AnnouncementsTravel Funds Available for CRAs to Attend the Spring 2022 Group Meeting
March 8, 2022 March 8, 2022Categories News StoriesJAMA Oncology publishes TAILORx data showing racial and neighborhood disparities in breast cancer
March 1, 2022 March 1, 2022Categories News StoriesFDA notes the NCI-MATCH trial in its release of new guidance on master protocols and expansion cohorts
